US OptionsDetailed Quotes
ARVN250516P10000
- 3.74
- 0.000.00%
15min DelayClose May 14 16:00 ET
0.00High0.00Low
3.74Open3.74Pre Close0 Volume19 Open Interest10.00Strike Price0.00Turnover0.00%IV-3.13%PremiumMay 16, 2025Expiry Date3.93Intrinsic Value100Multiplier1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma1.58Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Arvinas Stock Discussion
Sign in to post a comment
$Arvinas (ARVN.US)$ What happen bruh
2
2
Arvinas' high P/S ratio could be worrisome as revenue forecasts are not promising. The anticipated future revenues may not sustain the current positive sentiment. Without significant improvements, these prices may not be deemed reasonable.
1
Sean Cassidy expressed confidence in the company's future and the promising clinical development and commercial opportunity for the PROTAC(R) protein degrader pipeline. The company's leadership acknowledged Cassidy's pivotal role in creating Arvinas' strong financial profile.
2
$Arvinas (ARVN.US)$ I hope everyone bought that sub 14 dip! This thing has been a beast.
1
No comment yet
FMattDamon : 2027 When new FDA starts some bio will
T+32 watch list now